RS49658B - Primena alkil hidrogen fumarata za lečenje psorijaze, psorijatičnog artritisa, neurodermatitisa i enteritis regionalis-a crohn - Google Patents

Primena alkil hidrogen fumarata za lečenje psorijaze, psorijatičnog artritisa, neurodermatitisa i enteritis regionalis-a crohn

Info

Publication number
RS49658B
RS49658B YUP-320/00A YU32000A RS49658B RS 49658 B RS49658 B RS 49658B YU 32000 A YU32000 A YU 32000A RS 49658 B RS49658 B RS 49658B
Authority
RS
Serbia
Prior art keywords
neurodermatitis
psoriatic arthritis
alkyl hydrogen
treating psoriasis
regional enteritis
Prior art date
Application number
YUP-320/00A
Other languages
English (en)
Inventor
Kumar Rajendra Joshi
Hans-Peter Strebel
Original Assignee
Fumapharm Ag.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fumapharm Ag., filed Critical Fumapharm Ag.,
Publication of YU32000A publication Critical patent/YU32000A/sh
Publication of RS49658B publication Critical patent/RS49658B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Primena jednog ili više alkil hidrogen fumarata opšte formule u kojoj je R C1’5-alkil, u datom slučaju u smeši sa dialkil fumaratom formule i u datom slučaju uobičajenih ekspijenata i nosača za izradu farmaceutske kompozicije u obliku mikrotableta ili mikropeleta za lečenje psorijaze, psorijatičnog artritisa, neurodermatitisa i enteritis regionalis-a Crohn. Prijava sadrži još 6 patentnih zahteva.
YUP-320/00A 1998-03-31 1998-12-08 Primena alkil hidrogen fumarata za lečenje psorijaze, psorijatičnog artritisa, neurodermatitisa i enteritis regionalis-a crohn RS49658B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19814358A DE19814358C2 (de) 1998-03-31 1998-03-31 Verwendung von Alkylhydrogenfumaraten zur Behandlung von Psoriasis, psoriatischer Arthritis, Neurodermitis und Enteritis regionalis Crohn

Publications (2)

Publication Number Publication Date
YU32000A YU32000A (sh) 2002-03-18
RS49658B true RS49658B (sr) 2007-09-21

Family

ID=7863089

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-320/00A RS49658B (sr) 1998-03-31 1998-12-08 Primena alkil hidrogen fumarata za lečenje psorijaze, psorijatičnog artritisa, neurodermatitisa i enteritis regionalis-a crohn

Country Status (26)

Country Link
US (1) US6277882B1 (sr)
EP (1) EP1059920B1 (sr)
JP (1) JP3527890B2 (sr)
CN (1) CN1150898C (sr)
AT (1) ATE219936T1 (sr)
AU (1) AU745281B2 (sr)
BG (1) BG64744B1 (sr)
BR (1) BRPI9815772B8 (sr)
CA (1) CA2283915C (sr)
CZ (1) CZ291788B6 (sr)
DE (2) DE19814358C2 (sr)
DK (1) DK1059920T3 (sr)
EE (1) EE04702B1 (sr)
ES (1) ES2179551T3 (sr)
HK (1) HK1035134A1 (sr)
HU (1) HU228848B1 (sr)
IL (1) IL136835A (sr)
NO (1) NO327750B1 (sr)
NZ (1) NZ505341A (sr)
PL (1) PL191803B1 (sr)
PT (1) PT1059920E (sr)
RS (1) RS49658B (sr)
RU (1) RU2197233C2 (sr)
SK (1) SK285187B6 (sr)
TR (1) TR200001829T2 (sr)
WO (1) WO1999049858A1 (sr)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19839566C2 (de) * 1998-08-31 2002-01-17 Fumapharm Ag Muri Verwendung von Fumarsäurederivaten in der Transplantationsmedizin
DE19853487A1 (de) * 1998-11-19 2000-05-25 Fumapharm Ag Muri Verwendung von Dialkylfumaraten
RS52083B (sr) * 2001-01-12 2012-06-30 Fumapharm Ag Amidi fumarne kiseline
DE10101307A1 (de) * 2001-01-12 2002-08-01 Fumapharm Ag Muri Fumarsäurederivate als NF-kappaB-Inhibitor
DE10217314A1 (de) * 2002-04-18 2003-11-13 Fumapharm Ag Muri Carbocyclische und Oxacarboncyclische Fumarsäure-Oligomere
DE602004010531T2 (de) * 2003-09-09 2008-07-03 Fumapharm Ag Verwendung von fumarsäure-derivaten zur behandlung von herzinsuffizienz und asthma
DE10360869A1 (de) * 2003-09-09 2005-04-07 Fumapharm Ag Verwendung von Fumarsäurederivaten zur Therapie der Herzinsuffizienz, der Hyperkeratose und von Asthma
PL2801355T3 (pl) 2004-10-08 2015-10-30 Fwp Ip Aps Kompozycje farmaceutycznie o kontrolowanym uwalnianiu zawierające ester kwasu fumarowego
US20080004344A1 (en) * 2004-11-10 2008-01-03 Aditech Pharma Ab Novel Salts of Fumaric Acid Monoalkylesters and Their Pharmaceutical Use
WO2007006307A2 (en) * 2005-07-07 2007-01-18 Aditech Pharma Ab Novel salts of fumaric acid monoalkylesters and their pharmaceutical use
WO2007006308A1 (en) * 2005-07-07 2007-01-18 Aditech Pharma Ab Novel glucopyranose esters and glucofuranose esters of alkyl- fu marates and their pharmaceutical use
EP1951206A1 (en) * 2005-10-07 2008-08-06 Aditech Pharma AB Controlled release pharmaceutical compositions comprising a fumaric acid ester
EP1940382A2 (en) * 2005-10-07 2008-07-09 Aditech Pharma AB Combination therapy with fumaric acid esters for the treatment of autoimmune and/or inflammatory disorders
DK2139467T3 (da) * 2007-02-08 2017-01-02 Biogen Ma Inc Neurobeskyttelse i demyelinisationssygdomme
DK2653873T3 (da) 2007-02-08 2022-07-25 Biogen Ma Inc Sammensætninger og anvendelser til behandling af multipel sklerose
CA2730478C (en) 2008-08-19 2014-04-15 Xenoport, Inc. Prodrugs of methyl hydrogen fumarate
ES2411972T5 (es) 2009-01-09 2021-10-27 Fwp Ip Aps Formulación farmacéutica que comprende uno o más ésteres de ácido fumárico en una matriz de erosión
SI2718257T1 (en) 2011-06-08 2018-04-30 Biogen Ma Inc. PROCEDURE FOR PREPARATION OF HIGH QUALITY CRYSTALINIC DIMETHY OF FUMARAT
RU2014125430A (ru) 2011-11-24 2015-12-27 Синтон Бв Контролируемое высвобождение частиц, содержащих диметилфумарат
US20130158077A1 (en) 2011-12-19 2013-06-20 Ares Trading S.A. Pharmaceutical compositions
US9504679B2 (en) 2011-12-19 2016-11-29 Bjoern Colin Kahrs Pharmaceutical compositions comprising glitazones and Nrf2 activators
JP6189333B2 (ja) * 2012-02-07 2017-08-30 バイオジェン エムエー インコーポレーテッド フマル酸ジメチルを含有する医薬組成物
WO2013119791A1 (en) 2012-02-07 2013-08-15 Xenoport, Inc. Morpholinoalkyl fumarate compounds, pharmaceutical compositions, and methods of use
KR101449114B1 (ko) * 2012-08-21 2014-10-13 바이오스펙트럼 주식회사 푸마르산을 유효성분으로 포함하는 항염 조성물
JP2015526477A (ja) * 2012-08-22 2015-09-10 ゼノポート，インコーポレイティド メチル水素フマレートの経口剤形およびそのプロドラッグ
JP2015527372A (ja) * 2012-08-22 2015-09-17 ゼノポート，インコーポレイティド 副作用を低減させるモノメチルフマレートおよびそのプロドラッグの投与方法
US20140171504A1 (en) 2012-12-14 2014-06-19 Georgia Regents Research Institute, Inc. Methods of Treating Sickle Cell Disease and Related Disorders Using Fumaric Acid Esters
CN105142628A (zh) 2012-12-21 2015-12-09 比奥根玛公司 氘取代的富马酸盐衍生物
US8669281B1 (en) 2013-03-14 2014-03-11 Alkermes Pharma Ireland Limited Prodrugs of fumarates and their use in treating various diseases
NZ723459A (en) 2013-03-14 2017-12-22 Alkermes Pharma Ireland Ltd Prodrugs of fumarates and their use in treating various diseases
US10179118B2 (en) 2013-03-24 2019-01-15 Arbor Pharmaceuticals, Llc Pharmaceutical compositions of dimethyl fumarate
WO2014197860A1 (en) 2013-06-07 2014-12-11 Xenoport, Inc. Method of making monomethyl fumarate
WO2014205392A1 (en) 2013-06-21 2014-12-24 Xenoport, Inc. Cocrystals of dimethyl fumarate
EP3038605A1 (en) 2013-08-26 2016-07-06 Forward Pharma A/S Pharmaceutical composition containing dimethyl fumarate for administration at a low daily dose
EP3041467A1 (en) 2013-09-06 2016-07-13 XenoPort, Inc. Crystalline forms of (n,n-diethylcarbamoyl)methyl methyl (2e)but-2-ene-1,4-dioate, methods of synthesis and use
WO2015042294A1 (en) 2013-09-18 2015-03-26 Xenoport, Inc. Nanoparticle compositions of dimethyl fumarate
JP6337135B2 (ja) 2014-02-24 2018-06-06 アルカーメス ファーマ アイルランド リミテッド フマル酸エステルのスルホンアミドプロドラッグ及びスルフィンアミドプロドラッグ並びに種々の疾患の治療におけるその使用
US9999672B2 (en) 2014-03-24 2018-06-19 Xenoport, Inc. Pharmaceutical compositions of fumaric acid esters
US20170319548A1 (en) * 2014-09-12 2017-11-09 Tobira Therapeutics, Inc. Cenicriviroc combination therapy for the treatment of fibrosis
WO2016061393A1 (en) 2014-10-15 2016-04-21 Xenoport, Inc. Fumarate compounds, pharmaceutical compositions, and methods of use
KR102487136B1 (ko) 2015-02-08 2023-01-10 엘커메스 파마 아일랜드 리미티드 모노메틸푸마레이트 전구약물 조성물
DK3273951T3 (da) 2015-03-27 2020-11-02 Symbionyx Pharmaceuticals Inc Sammensætninger og fremgangsmåder til behandling af psoriasis
WO2017060420A1 (en) 2015-10-07 2017-04-13 Neurovive Pharmaceutical Ab Protected fumaric acid-based metabolites for the treatment of autoimmune diseases
CN105496804A (zh) * 2015-12-25 2016-04-20 知识产权全资有限公司 用于处理头发以及治疗头部牛皮藓的配方及其试剂盒和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2530372A1 (de) * 1975-07-08 1977-01-13 Walter Dr Schweckendiek Pharmazeutische zubereitungen zur behandlung von psoriasis
DE2621214C3 (de) * 1976-05-13 1981-11-12 Koronis Gmbh Chemisch-Pharmazeutische Praeparate, 5441 Sassen Verwendung von Stabilisatoren in Arzneimitteln mit Fumarsäuremonoäthylester und desen Mineralsalzen
DE3127432A1 (de) * 1981-07-11 1983-02-03 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von fumarsaeuremonoester
US5242905A (en) * 1987-09-04 1993-09-07 Dexter Chemical Corporation Pharmaceutical compositions for the treatment of psoriasis
US5214196A (en) * 1987-09-04 1993-05-25 Dexter Chemical Corporation Diethyl ester of di-glycyl fumaramide
US4959389A (en) * 1987-10-19 1990-09-25 Speiser Peter P Pharmaceutical preparation for the treatment of psoriatic arthritis
US5424332A (en) * 1987-10-19 1995-06-13 Speiser; Peter P. Pharmaceutical composition and process for the production thereof
DE8714143U1 (sr) * 1987-10-23 1988-03-24 Werler Kunststoffwerke Gmbh & Co, 4760 Werl, De
DE3834794A1 (de) * 1988-10-12 1990-04-19 F Schielein Oral zu verabreichendes mittel zur behandlung von psoriasis
WO1992012952A1 (en) * 1991-01-18 1992-08-06 Dexter Chemical Corporation Malic acid derivatives and compositions for the treatment of psoriasis
US5407772A (en) * 1993-11-30 1995-04-18 Xerox Corporation Unsaturated polyesters
US5972363A (en) * 1997-04-11 1999-10-26 Rohm And Haas Company Use of an encapsulated bioactive composition

Also Published As

Publication number Publication date
RU2197233C2 (ru) 2003-01-27
EP1059920A1 (de) 2000-12-20
DE19814358A1 (de) 1999-10-07
BG64744B1 (bg) 2006-02-28
BRPI9815772A (pt) 2000-11-21
US6277882B1 (en) 2001-08-21
NZ505341A (en) 2002-04-26
HUP0103234A2 (hu) 2002-01-28
AU2159399A (en) 1999-10-18
IL136835A0 (en) 2001-06-14
DK1059920T3 (da) 2002-10-14
HU228848B1 (en) 2013-06-28
HK1035134A1 (en) 2001-11-16
YU32000A (sh) 2002-03-18
AU745281B2 (en) 2002-03-21
DE59804704D1 (de) 2002-08-08
CA2283915C (en) 2002-12-03
NO327750B1 (no) 2009-09-14
SK285187B6 (sk) 2006-08-03
EE200000440A (et) 2001-12-17
EE04702B1 (et) 2006-10-16
PL191803B1 (pl) 2006-07-31
ES2179551T3 (es) 2003-01-16
PL341240A1 (en) 2001-03-26
PT1059920E (pt) 2002-11-29
BRPI9815772B8 (pt) 2021-07-06
CA2283915A1 (en) 1999-09-30
BG104566A (en) 2001-01-31
TR200001829T2 (tr) 2000-11-21
EP1059920B1 (de) 2002-07-03
HUP0103234A3 (en) 2003-11-28
CN1284870A (zh) 2001-02-21
BRPI9815772B1 (pt) 2016-02-10
DE19814358C2 (de) 2002-01-17
ATE219936T1 (de) 2002-07-15
CZ291788B6 (cs) 2003-05-14
CZ20003086A3 (cs) 2000-11-15
NO20002872L (no) 2000-06-06
JP2002509883A (ja) 2002-04-02
JP3527890B2 (ja) 2004-05-17
NO20002872D0 (no) 2000-06-06
WO1999049858A1 (de) 1999-10-07
CN1150898C (zh) 2004-05-26
SK7922000A3 (en) 2001-01-18
IL136835A (en) 2005-05-17

Similar Documents

Publication Publication Date Title
RS49658B (sr) Primena alkil hidrogen fumarata za lečenje psorijaze, psorijatičnog artritisa, neurodermatitisa i enteritis regionalis-a crohn
RS49775B (sr) Primena soli monoalkil estara fumarne kiseline u obliku mikrotableta za lečenje
BRPI9909282A (pt) compostos de éter aminociclohexílicos e usos dos mesmos.
HK56897A (en) Benzocyclobutyl-or indanyl-alkyl-amino-alkyl substituted 3-benzazepin-2-ones useful in the treatment of cardiovascular diseases
EP0350846A3 (en) Condensed heterocyclic compounds and their use in therapy
MY132705A (en) Novel compounds with analgesic effect
ES2062239T3 (es) Diamidas de acidos pirimidin-4,6-dicarboxilicos, procedimiento para su preparacion, utilizacion de las mismas, asi como medicamentos a base de estos compuestos.
PL356100A1 (en) Lipoxin a4
GB9418912D0 (en) Pharmaceutically active compounds
ES2106531T3 (es) Compuestos de dibenzoxazepina substituidos en 2, 3, 4, 5, 6, 7, 8, 9 y/o 10, composiciones farmaceuticas y metodos de uso.
PL316656A1 (en) Free halophantrin base for use in treating marsh-fever and compositions containing same
PL313078A1 (en) Novel bis-naphtalimides for use in treating carcinoma
EA200000242A1 (ru) Применение фанхинона для лечения болезни альцгеймера
MX9300203A (es) Compuestos policiclicos disubstituidos y composicion farmaceutica que los contiene.
ES8707204A1 (es) Procedimiento para preparar diazepinoindoles
GEP20002141B (en) Use of 2-Phenyl-1, 2-Benzisoselenazol-3(2H)-One for Prevention and/or Treatment of Dementia, a Pharmaceutical Composition for Prevention and/or Treatment of the Alzheimer’s Disease
IT1255373B (it) 5-nitro-metil-imidazolil-3-terbutil-2-idrossi- aril-carbinoli,un processo per la loro preparazione e relative composizioni terapeutiche.
RS49595B (sr) Primena 2-fenil-1,2- benzizoselenazol-3(2h)-ona za izradu farmaceutskog preparata za lečenje alchajmerove bolesti
MY110416A (en) Composition for the treatment of schizophrenia.